WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MCRB

Based on 3 analysts offering 12 month price targets for Seres Therapeutics Inc.
Min Forecast
$1.25+102.27%
Avg Forecast
$4.75+668.61%
Max Forecast
$8.00+1,194.5%

Should I buy or sell MCRB stock?

Based on 3 analysts offering ratings for Seres Therapeutics Inc.
Hold
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their MCRB stock forecasts and price targets.

MCRB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2023-11-03

1 of 1

Forecast return on equity

Is MCRB forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is MCRB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MCRB revenue forecast

What is MCRB's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$300.0k-99.76%
Avg 2 year Forecast
$104.0M-17.7%
Avg 3 year Forecast
$9.6M-92.42%
MCRB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MCRB revenue growth forecast

How is MCRB forecast to perform vs Biotechnology companies and vs the US market?
Company
5.95%
Industry
38.51%
Market
10.3%
MCRB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MCRB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MCRB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MCRB$0.62$4.75+668.61%Hold
MIST$1.76$15.00+754.70%Strong Buy
ELTX$9.23$11.00+19.18%Buy
CNTB$1.67$7.00+319.16%Buy
ALLK$1.08$1.83+69.72%Hold
View Top Biotech Stocks

Seres Therapeutics Stock Forecast FAQ

Is Seres Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MCRB) stock is to Hold MCRB stock.

Out of 3 analysts, 1 (33.33%) are recommending MCRB as a Strong Buy, 1 (33.33%) are recommending MCRB as a Buy, 0 (0%) are recommending MCRB as a Hold, 0 (0%) are recommending MCRB as a Sell, and 1 (33.33%) are recommending MCRB as a Strong Sell.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.

What is MCRB's revenue growth forecast for 2024-2027?

(NASDAQ: MCRB) Seres Therapeutics's forecast annual revenue growth rate of 5.95% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.3%.

Seres Therapeutics's revenue in 2024 is $126,325,000.On average, 1 Wall Street analysts forecast MCRB's revenue for 2024 to be $45,302,839, with the lowest MCRB revenue forecast at $45,302,839, and the highest MCRB revenue forecast at $45,302,839. On average, 1 Wall Street analysts forecast MCRB's revenue for 2026 to be $15,698,943,670, with the lowest MCRB revenue forecast at $15,698,943,670, and the highest MCRB revenue forecast at $15,698,943,670.

In 2027, MCRB is forecast to generate $1,445,160,551 in revenue, with the lowest revenue forecast at $1,445,160,551 and the highest revenue forecast at $1,445,160,551.

What is MCRB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MCRB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MCRB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year MCRB price target, the average MCRB price target is $4.75, with the highest MCRB stock price forecast at $8.00 and the lowest MCRB stock price forecast at $1.25.

On average, Wall Street analysts predict that Seres Therapeutics's share price could reach $4.75 by Mar 6, 2025. The average Seres Therapeutics stock price prediction forecasts a potential upside of 668.61% from the current MCRB share price of $0.62.

What is MCRB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MCRB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.